








key: cord-325055-todb1d4x
authors: Rychter, Anna Maria; Zawada, Agnieszka; Ratajczak, Alicja Ewa; Dobrowolska, Agnieszka; Krela‐Kaźmierczak, Iwona
title: Should patients with obesity be more afraid of COVID‐19?
date: 2020-06-24
journal: Obes Rev
DOI: 10.1111/obr.13083
sha: 
doc_id: 325055
cord_uid: todb1d4x

COVID‐19 crisis has lasted since the late 2019 to the present day. The severity of the disease is positively correlated with several factors, such as age and coexisting diseases. Furthermore, obesity is increasingly considered as a yet another risk factor, particularly, because it has been observed that people suffering from excessive body weight may experience a more severe course of COVID‐19 infection. On the basis of current research, in our nonsystematic review, we have investigated the extent to which obesity can affect the SARS‐CoV‐2 course and identify the potential mechanisms of the disease. We have also described the role of proper nutrition, physical activity and other aspects relevant to the management of obesity.

The crisis caused by coronavirus disease 2019 , also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began in late 2019 in Wuhan (capital of Hubei, China) and has spread worldwide in early 2020. 1, 2 According to World Health Organization (WHO) report of May 16, since the beginning of the outbreak over 4 million cases have been confirmed, more than 300 000 of which have been fatal. 3 However, we are also facing another pandemic-the global prevalence of obesity almost tripled between 1975 and 2016, and it is currently estimated that over 2 billion people suffer from excessive body weight. 4, 5 The current estimates indicate that obesity rates will continue to rise until at least 2030. 6 It is generally accepted that obesity is associated with an increased overall mortality, where the life expectancy of an individual suffering from severe obesity is reduced by 5-20 years. 7 Moreover, it also increases the risk of developing several co-morbidities, also associated with the severity of the COVID-19 infection, such as cardiovascular disease (CVD), type 2 diabetes (T2DM), kidney disease or numerous types of cancer. 8, 9 Additionally, obesity also increases the risk of developing pneumonia and other viral respiratory tract infections. 10, 11 Due to the fact that excessive body weight constitutes a serious global issue, it requires even more attention because it is presumably associated with the severity of the current COVID-19 pandemic.

Although the current data are scarce, in our nonsystematic review, we have tried to investigate how many of SARS-CoV-2 patients suffer from obesity and to identify the potential mechanisms which would further explain the association between obesity and SARS-CoV-2 severity. Moreover, we have also described both nutritional and behavioural aspects which could provide a basis for the potential guidelines.

Although the data regarding the impact of SARS-CoV-2 in individuals with obesity are limited and their association has not been fully defined yet, it has been observed that people suffering from excessive body weight may experience a more serious COVID-19 infection. 12, 13 It is particularly evident in individuals who are affected by other risk factors mentioned earlier, which associated with a more severe course of the disease. This association was also observed during influenza A pandemic in 2009, where obesity was recognized as an independent risk factor of complications. In fact, patients with obesity, following a high-fat diet, suffered over 40% longer than those without excessive body weight. 14,15 Therefore, it seems that obesity during COVID-19 outbreak requires more attention, especially in the western countries where the prevalence of obesity is high. 16 According to the COVID-19-Associated Hospitalization Surveillance Network in the United States at the turn of March 2020, 48% of hospitalized patients presented obesity (range across age groups = 41-59%). 17 

The receptor for COVID-19, similarly to other coronaviruses, has a high affinity for human angiotensin-converting enzyme-2 (ACE-2), expressed in type 1 and 2 alveolar epithelial cell and endothelium, but also in such organs as the heart, endothelium, pancreas and the intestinal epithelium. 27 In fact, ACE-2 is considered to be the receptor allowing the entry of COVID-19 into the host cells by means of the activation of the renin-angiotensin-system (RAS). 28 SARS-CoV-2 affinity for the ACE-2 receptor is higher than in the case of SARS-CoV. 29 It is vital to point out that the adipose tissue might be prone to SARS-CoV-2 because the expression of ACE-2 is higher in adipose tissue than in the lung tissue. 15 Nevertheless, there is no current evidence for direct COVID-19 infection of adipose tissue. 26, 30, 31 At this point, it should be emphasized that the existing recommendations do not advise a discontinuation of ACE inhibitors and angiotensin receptor blockers, used nowadays as a treatment for hypertension unless the physician recommends otherwise. 32, 33 'Cytokine storm' , that is, one of the mechanisms responsible for the severity of COVID-19, is the hyperactivation of the immune system and is associated with an increased level of interleukin (IL)-6, interferon γ and other proinflammatory cytokines. 34 38, 39 Leptin is involved in the surfactant production and the development of lungs in the neonatal period, but it also participates in the ventilatory drive regulation. 40 Another adipokine-omentin may play a role in the pathogenesis of asthma; however, it can also have a protective effect on the pulmonary endothelial function and decrease pulmonary permeability and inflammation. 41 Reduced omentin, ghrelin and adiponectin levels were observed in individuals suffering from obstructive sleep apnea (OSA). 41, 42 Obesity can also predispose to a greater viral shedding, leading to a greater viral exposure. 37 Because obesity-related co-morbidities are commonly identified among COVID-19 individuals, they can also account for additional risk factors regarding the severity of COVID-19

complications in obesity. 34, 43, 44 Obesity predisposes to several comorbidities and mechanisms which lead to a more severe course of COVID 19. 10 Although, these co-morbidities were mentioned before, it is crucial to stress that metabolic disorders, such as hypertension, insulin resistance, dyslipidemia or prediabetes, which frequently occur in patients suffering from obesity, also predispose to a poorer COVID-19 outcome. 8, 9, 43 Furthermore, research studies indicate that individuals suffering from obesity present lower vitamin D levels. 45 The characteristics of patients with obesity regarding possible factors affecting a more severe COVID-19 course are shown in Table 2 .

Most of the COVID-19 patients present symptoms of a respiratory disease. 51, 52 Hospitalization rates and the number of respiratory infections are higher in individuals with obesity than in normal-weight patients. 40 The likely mechanisms which emphasize these effects are poorly understood, but it is suggested that obesity-induced imbalances in adipokine levels could impair pulmonary vascular endothelial function and cause lung damage. 61 Furthermore, not only has leptin been

The characteristic of patients with obesity-associated with high risk and worse outcome of COVID-19

Pulmonary function Pulmonary oedema, lung damage, increased pulmonary vascular permeability, impaired gas exchange, reduced oxygen saturation of blood, decreased ERV and FRC, lower muscle strength, lower lung volume involved in the physiological but also in the pathological conditions of the respiratory system, such as COPD, OSA and asthma. 62 In fact, due to high leptin levels among patients with obesity, leptin resistance can be the result of upregulation of SOCS-3, which also negatively regulates antiviral interferons (INFs) signalling. 63 Furthermore, IFN deficiency might constitute the link between the risk factors, such as obesity, and the severity of pulmonary disorders. 62

Several studies demonstrated that individuals with excessive body weight had improved survival rates, or a chronic disease prognosis, for example, of CVD when compared with healthy body weight individuals. [64] [65] [66] [67] This phenomenon was called 'the obesity paradox'

and, according to CVD disease, it may relate to even 30% of patients with obesity. 68 Whether the obesity paradox will be present among COVID-19 patients remains to be seen, nevertheless, the phenomenon was reported among other respiratory diseases, such as COPD or ARDS. 53, 69 Its pathophysiological basis remains unknown; however, an increased BMI seems to be associated with a better survival and a slower decline in the lung function in patients with a mild course of chronic obstructive pulmonary disease. 70 It may be partially explained by the fact that a severe form of COPD can lead to weight loss and later to cachexia-it would seem that obesity would prevent this. 71 Moreover, the obesity paradox in COPD could also be explained by adipokines, because certain individuals can have a more 'favourable' adipokine profile. 71 Regardless of the obesity paradox in COPD, a low-energy diet which leads to weight loss, combined with physical activity, is still recommended among patients with obesity and respiratory disorders. 72 It alleviates the symptoms and improves the functional capacity and strength, as well as helps to maintain a freefat mass.

To the best of our knowledge, there are no specific guidelines concerning the nutritional treatment of COVID-19 patients with obesity.

However, such organizations as WHO, or The European Association for the Study of Obesity (EASO) have prepared nutritional guidelines and tips regarding nutrition during quarantine. 73-76 It seems obvious that because obesity possibly is associated with the severity of COVID-19, it is recommended to apply a hypocaloric diet to reduce body weight. 31 What is more, weight loss is also beneficial in terms of lung function. 77 Several behavioural and nutritional aspects could be essential among patients with obesity, and they should be considered when preparing future guidelines.

On the basis of the existing knowledge, an adequate intake of vitamins A, E, B3, B6, B12, D, and folate, as well as zinc, copper, selenium, iron, and omega-3 polyunsaturated fatty acids is essential for the maintenance of proper immune function. 36, 75, [78] [79] [80] Although micronutrient insufficiency and nutritional status increase the risk of COVID-19 infection and could worsen its outcome, the use of supraphysiologic amounts to improve the course of COVID-19 is not currently recommended. 81, 82 However, studies have demonstrated that the intake of several vitamins and micronutrients, such as vitamin A, C, B1, potassium, magnesium, calcium, or iron is usually insufficient in patients suffering from obesity and therefore should be taken into account. 83 Whether vitamin D supplementation should be increased in COVID-19 period remains unclear and is not currently recommended. In fact, more randomized-controlled trials should be performed to confirm these suggestions. 84 It has been shown that a high consumption of saturated fatty acids (SFAs) can induce lipotoxic state, cause adipose tissue inflammation and promote the activation of the innate immune system due to the activation of toll-like receptor 4 (TRL-4). 85, 86 In the animal model, a high-fat diet induced MCP-1 for macrophage infiltration into the lung tissue and an increased lipopolysaccharide induced interleukin-1β

and tumour necrosis factor α (TNFα) production. 87 A high intake of both protein and fat may be associated with higher levels of plasma interleukin-6 and TNFα. 88 However, the interaction between nutrition and immunology is extensive and very complex; thus, more randomized-controlled trials should be conducted in this area. 89 Psychosocial burdens, for example, stress or depression, have been associated with obesity, and a psychological support is an essential approach to managing obesity. 90 During COVID-19 pandemic, increased psychological distress was observed both in infected individuals and in the general population. 91 Additionally, social isolation was found to be a predictor of an increased mortality, as well as a possible cause of depression and anxiety in the youth. 92, 93 It is worth noticing that individuals suffering from obesity are usually more vulnerable to distress and psychological impact of COVID-19 quarantine can influence the proper obesity management. 94 Psychological distress can also lead to a binge and emotional eating among bariatric surgery patients (in time before or after the surgery), which can be associated with poorer long-term results. 94 However, the association between psychological aspects and obesity during the current epidemiological situation needs to be further investigated; psychological support should definitely constitute one of the elements of the proper obesity management during COVID-19 pandemic.

Although the recent statistics are limited, it could be assumed that during the prolonged SARS-CoV-2 quarantine the level of physical activity is lower than usual. In fact, physical inactivity not only predisposes to weight gain but can also lead to the loss of strength, skeletal muscle mass and immune competence. 82 It is vital to bear in mind that quarantine reduced the physical activity level not only for habitually, physically active individuals but also for those whose activity was associated with work, or school, as well as those who mainly work physically. 93 ventilation-acquired dysphagia in SARS-CoV-2 survivors could be a challenge and will require a special nutritional support.

We would like to thank the TranslationLab, a biomedical translation company, for linguistic proofreading.

The authors declare no conflict of interest. 

Severe acute respiratory syndrome-related coronavirus: The Species and Its Viruses -a Statement of the Coronavirus Study Group

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges

World Health Organization. Coronavirus disease (COVID-19). Situation report-118

Obesity: global epidemiology and pathogenesis

Morbidity and mortality associated with obesity

Clinical characteristics of coronavirus disease 2019 in China

Epidemiology and clinical characteristics of COVID-19

Obesity and impaired metabolic health in patients with COVID-19

Chloroquine for SARS-CoV-2: implications of its unique pharmacokinetic and safety properties

COVID-19 and endocrine diseases. A statement from the

COVID-19 and obesity. Clin Obes

Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice

Risk of COVID-19 for patients with obesity

COVID 19 and the patient with obesity-the editors speak out

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 States

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

ICNARC report on COVID-19 in critical care

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. Intensive Care and Critical Care Medicine

Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia

Interaction between gut microbiome and cardiovascular disease

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Obesity hypoventilation syndrome and severe COVID-19

Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19

Association of obesity with disease severity among patients with COVID-19. Obesity. Published online

Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection swith reference to use of therapeutic and other drugs used in co-morbid diseases (hypertension, diabetes etc)

Targeting the adipose tissue in COVID-19

COVID-19, SARS and MERS: are they closely related?

Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19

The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections

Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. American Heart Association

Addresses Concerns Re: using RAAS antagonists in COVID-19 -American College of Cardiology

Obesity: the "Achilles heel" for COVID-19?

Obesity and SARS-CoV-2: a population to safeguard

COVID-19 infection: the perspectives on immune responses

Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms

Obesity and lung function: a systematic review

Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression

The effect of obesity on lung function

Omentin-A novel adipokine in respiratory diseases

Adiponectin, omentin, ghrelin, and visfatin levels in obese patients with severe obstructive sleep apnoea

Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Vitamin D and obesity in adults: a pathophysiological and clinical update

Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization study

Obesity and overweight decreases the effect of vitamin D supplementation in adults: systematic review and meta-analysis of randomized controlled trials

Low vitamin D status and obesity: role of nutritionist

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths

Considerations for obesity, vitamin D, and physical activity amidst the COVID-19 pandemic. Obesity

A new coronavirus associated with human respiratory disease in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Body weight and mortality in COPD: focus on the obesity paradox

Pathophysiology and management of acute respiratory distress syndrome in obese patients

The effects of obesity on lung volumes and oxygenation

The effects of body mass index on lung volumes

Obesity and acute lung injury

Effect of body mass index in acute respiratory distress syndrome

High positive end-expiratory pressure is associated with improved survival in obese patients with acute respiratory distress syndrome

Tracheal trauma after difficult airway management in morbidly obese patients with COVID-19

Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury

Obesity and susceptibility to severe outcomes following respiratory viral infection

Obesity and respiratory infections: does excess adiposity weigh down host defense?

Association of body mass index with mortality in cardiovascular disease: new insights into the obesity paradox from multiple perspectives

Obesity paradox in patients with hypertension and coronary artery disease

Obesity phenotypes and their paradoxical association with cardiovascular diseases

Are metabolically healthy obese patients also hemorheologically healthy?

Metabolically healthy obesity and risk of allcause and cardiovascular disease mortality

Does COVID-19 disprove the obesity paradox in ARDS? Obesity

Respiratory function and the obesity paradox

BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials

Should we treat obesity in COPD? The effects of diet and resistance exercise training: treating the obesity paradox

Practical advice on maintaining health during COVID-19 pandemic

Practical advice on supporting health during the COVID-19 pandemic

Nutritional recommendations for CoVID-19 quarantine

Food and nutrition tips during self-quarantine

Obesity and its impact on the respiratory system

Nutrition amid the COVID-19 pandemic: a multilevel framework for action

Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections

Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection

Krela-Kaźmierczak I. Non-systematic review of diet and nutritional risk factors of cardiovascular disease in obesity

High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial

The impact of nutrition on COVID-19 susceptibility and long-term consequences

The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease

Saturated fatty acid increases lung macrophages and augments house dust mite-induced airway inflammation in mice fed with high-fat diet

The effect of habitual fat intake, IL6 polymorphism, and different diet strategies on inflammation in postmenopausal women with central obesity

Nutrition and the immune system: a complicated tango

Stress and obesity

The differential psychological distress of populations affected by the COVID-19 pandemic

Social isolation: a predictor of mortality comparable to traditional clinical risk factors

Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)

The impact of COVID-19 on bariatric surgery: re-defining psychosocial care

Does high cardiorespiratory fitness confer some protection against proinflammatory responses after infection by SARS-CoV-2? Obesity

Exercise against SARS-CoV-2 (COVID-19): Does workout intensity matter? (A mini review of some indirect evidence related to obesity)

Krela-Kaźmierczak I. Should patients with obesity be more afraid of COVID-19?



